register

Medical and Science

NSW funding to tackle 3,000 extra emergency visits per 1% drop in bulk billing

Health Industry Hub | June 19, 2024 |

Medical: An Australian-first move aims to encourage GPs to bulk bill and ease pressure on public hospitals.

The NSW government has budgeted $189m to give rebates to GP clinics that bulk bill for most patients while axing historical payroll tax issues.

Under the new scheme, clinics that meet a bulk-billing threshold of 80% in Sydney and 70% in the rest of the state will receive a payroll tax rebate for contractor GPs.

As it stands, payroll tax has not been collected from GP clinics due to a moratorium implemented by the state government until September 4. It’s expected the rebate will stop GP practices from passing on payroll tax costs to patients while also reducing pressure on public hospital emergency departments.

NSW Health data estimates that a 1% decrease in bulk billing equates to about an extra 3000 emergency department presentations.

The government will introduce legislation to enact the rebate and waive past unpaid payroll tax liability for contractor GPs that’s incurred up until September 4. Industry bodies had warned that historical tax debts could result in GPs closing shop or increasing the cost of GP appointments by as much as $20 per visit.

NSW Finance Minister Courtney Houssos said the policy would act “in concert” with the federal government’s $1.5bn measure to ensure GPs receive 34 per cent more for standard bulk-billed consultations that came into affect late last year.

“We want to be able to support our GPs who are providing bulk-billing services,” she said.

“The previous budget from the federal Labor government has increased bulk-billing rebates, but they only started to flow to doctors in November last year. We expect that over time, they will continue to have effect and hopefully we will see increases in bulk billing.”

However, NSW Opposition Leader Mark Speakman questioned whether the proposed rebates would increase bulk-billed appointments, as payroll tax to date had never been enforced on GPs.

While he welcomed the policy, he said it didn’t represent “cost-of-living relief”.

“It will not make GP visits cheaper. It just won’t increase the cost of going to a GP, which might otherwise have been the case if the payroll tax had been enforced,” he said.

Despite this, peak bodies including the Australian Medical Association (AMA) and the Royal Australian College of General Practioners (RACGP) welcomed the changes.

“Legislating ‘no retrospectivity’ will provide certainty for practices and will minimise the risk of more closures of general practices in NSW,” AMA NSW Director Michael Bonning said. “Unfortunately, general practice continues to struggle with decades of underfunding from the previous Coalition government.”

RACGP NSW and ACT chair, Rebekah Hoffman, said the retrospective payroll tax measure would allow more GPS to operate with certainty without facing a huge tax bill that could have “shut them down”.

“We appreciate the very tight budgetary constraints the NSW government is under and know this decision wasn’t taken lightly,” she stated.

To address the pressures on hospitals, the NSW government has also announced $481 million in spending to help hospital emergency departments under pressure. Around $3.4 billion will be poured into upgrading NSW hospitals and health facilities: nearly $1 billion of this will go towards facilities in rural and regional NSW.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech CEOs set agenda for the new year

Medicines Australia and AusBiotech CEOs set agenda for the new year

Health Industry Hub | January 16, 2025 |

Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]

More


News & Trends - MedTech & Diagnostics

MTAA and PTA CEOs voice outlook for the year ahead

MTAA and PTA CEOs voice outlook for the year ahead

Health Industry Hub | January 16, 2025 |

Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]

More


ESG

Boehringer Ingelheim sets sustainability benchmark in NZ

Boehringer Ingelheim sets sustainability benchmark in NZ

Health Industry Hub | January 16, 2025 |

Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the […]

More


News & Trends - Pharmaceuticals

Scathing report exposes Labor’s mismanagement of the PBS

Scathing report exposes Labor’s mismanagement of the PBS

Health Industry Hub | January 16, 2025 |

The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]

More


This content is copyright protected. Please subscribe to gain access.